Main Page Side Effects Insurance Coverage Review Board

Mounjaro 7.5mg Constipation — What to Take

Treating Constipation at Mounjaro 7.5mg

Constipation is one of the most common side effects at the 7.5mg dose. With 7.5mg of Mounjaro strong enough effects to noticeably slow GI transit time.

The Dose Factor

Every dose increase incrementally decreases how fast things move. This dose users commonly report that constipation becomes an issue.

Physiologically: Mounjaro at 7.5mg decreases peristalsis that move waste along. Fecal matter remains in the colon, becoming dehydrated with each additional period.

Treatment Protocol for Mounjaro 7.5mg Constipation

Tier 1: Daily Prevention

  • MiraLAX (17g daily) — the gold standard for Mounjaro constipation. Add to your morning beverage. Gentle and predictable.

  • Hydration (80-100+ oz water) — non-negotiable at 7.5mg. Your colon extracts more water at higher doses because transit time is even longer.

  • Fiber (Metamucil or Citrucel) — provides material for your colon to move. Start with half a dose and drink extra fluid.

Tier 2: Boosters

  • Colace (Docusate sodium 100-200mg) — supplements the MiraLAX effect. With meals.

  • Mag07 (3-5 capsules, 2-3x/week) — the overnight reset. Take on empty stomach before bed.

When You Haven’t Gone in 4+ Days

  • Dulcolax (bisacodyl 5-10mg) — stimulant laxative for rescue use only. Evening dosing. Don’t use daily.

  • Dulcolax suppository — fastest OTC option. When you need results now.

Lifestyle Adjustments at 7.5mg

  • Daily movement — exercise is a natural laxative
  • When you feel the need, go immediately — the urge won’t wait forever on Mounjaro
  • Morning bathroom time after coffee — consistency trains your body
  • Elevate your feet on the toilet — makes passage easier

If constipation at 7.5mg doesn’t respond to OTC treatment, talk to your prescriber — the provider might slow the titration to allow adaptation.

References

  1. FDA Prescribing Information for GLP-1 receptor agonists. U.S. Food and Drug Administration. 2024.
  2. SURPASS and SURMOUNT clinical trial programs. Eli Lilly and Company. 2022-2025.
  3. SUSTAIN and STEP clinical trial programs. Novo Nordisk. 2017-2024.
  4. American Diabetes Association Standards of Care in Diabetes. 2025.
  5. American Society of Health-System Pharmacists (ASHP) Drug Information. 2025.